Laurence joined SV Health as Chief Business Officer of the DDF.
Prior to this, Laurence was Head of Investment Management in Worldwide Business Development at GSK where he was responsible for managing GSK’s venture investment portfolio. In addition, he led licensing transactions for the pharma R&D business. Prior to GSK, Laurence worked in business development at biotech companies Syntaxin and MorphoSys.
Laurence holds an MBA from Cambridge and a PhD in Biochemistry from the University of Tübingen, Germany.